- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有127家主力机构披露2026-06-30报告期持股数据，持仓量总计9.78亿股，占流通A股38.63%
- 波段诊断：
-
技术面诊股
诊断结果：3.9技术面打败了12%的股票
技术面评分前10的股票
近期的平均成本为4.14元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为4.14元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.14","date":1794472591,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。
[{"date":"2026.11.13","stock":"-0.48","trade":"-1.88","ind":"-0.59"},{"date":"2026.11.12","stock":"-1.19","trade":"-0.19","ind":"-0.67"},{"date":"2026.11.11","stock":"-0.71","trade":"-0.53","ind":"0.46"},{"date":"2026.11.10","stock":"-0.47","trade":"0.88","ind":"0.08"},{"date":"2026.11.09","stock":"-0.47","trade":"-0.20","ind":"0.32"},{"date":"2026.11.06","stock":"-2.07","trade":"-0.80","ind":"-1.10"},{"date":"2026.11.05","stock":"-0.46","trade":"1.29","ind":"0.10"},{"date":"2026.11.04","stock":"0.23","trade":"0.85","ind":"2.16"},{"date":"2026.11.03","stock":"2.35","trade":"0.44","ind":"-0.82"},{"date":"2026.11.02","stock":"1.19","trade":"1.93","ind":"1.08"},{"date":"2026.10.30","stock":"0.96","trade":"-0.03","ind":"-1.44"},{"date":"2026.10.29","stock":"0.24","trade":"-1.62","ind":"-0.82"},{"date":"2026.10.28","stock":"-0.24","trade":"0.86","ind":"0.91"},{"date":"2026.10.27","stock":"-2.34","trade":"-2.32","ind":"-1.33"},{"date":"2026.10.26","stock":"1.43","trade":"0.48","ind":"0.19"},{"date":"2026.10.23","stock":"0.96","trade":"0.88","ind":"0.89"},{"date":"2026.10.22","stock":"-2.80","trade":"-2.52","ind":"-1.48"},{"date":"2026.10.21","stock":"-0.46","trade":"-0.15","ind":"-0.60"},{"date":"2026.10.20","stock":"-0.46","trade":"-0.28","ind":"0.12"},{"date":"2026.10.19","stock":"1.41","trade":"0.26","ind":"0.39"},{"date":"2026.10.16","stock":"0.23","trade":"-0.12","ind":"0.24"}]
康恩贝,上证指数,中药指数
压力支撑
该股压力位为4.14元，支撑位为4.10元。
[{"text":"\u538b\u529b\u4f4d","value":"4.14","date":1794499200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.10","date":1794499200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.5资金面打败了1%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月13日 20:30
| 机构今日流向(万元) | -1676.34 | 机构5日流向(万元) | -6423.53 |
| 机构10日流向(万元) | -3790.27 | 机构20日流向(万元) | -6988.91 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少9539.69万股，其中基金净减仓4家，主力净减仓159家，请投资者中长期谨慎为宜。
截止2026-06-30，共127家主力机构（基金121家，一般法人5家，其他资管计划1家），持仓量总计97812.51万股，占流通A股38.63%
其中，基金持仓与2025-12-31相比：
增仓：43家 ，增持 2143.48万股
减仓：47家 ，减持 3746.62万股
新出现在主力名单中：29家 ，持有6053.92万股
从主力名单中消失：188家 ，原持有5856.27万股
其中，基金持仓与2025-12-31相比：
增仓：43家 ，增持 2143.48万股
减仓：47家 ，减持 3746.62万股
新出现在主力名单中：29家 ，持有6053.92万股
从主力名单中消失：188家 ，原持有5856.27万股
消息面诊股
诊断结果：5.5消息面打败了57%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 康恩贝：11月12日获融资买入1647.43万元
2026-11-13 - 康恩贝：关于2022年股票期权激励计划部分股票期权
2026-11-12 - 康恩贝：11月11日获融资买入1638.08万元
2026-11-12 - 康恩贝：11月10日获融资买入873.40万元
2026-11-11 - 鱼油包装上的97%、98%、90%怎么看？特元素等
2026-11-10 - 季报点评】康恩贝：26Q1-Q3收入稳健增长，扣非
2026-11-10 - 康恩贝：11月9日获融资买入811.01万元
2026-11-10 - 成都药企拿下两大畅销药
2026-11-09 - 康恩贝：11月6日获融资买入1468.66万元
2026-11-07 - 行业周报|中药指数涨3.74%, 跑赢上证指数2.
2026-11-06
消息列表
| 一般消息 | 募资投向 | 公司出售资产 | 2026-09-01 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-26 |
| 一般消息 | 高管变动 | 调整 | 2026-08-24 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2026-06-30 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-18 |
| 一般消息 | 高管变动 | 工作调整 | 2026-06-17 |
| 利好 | 分红转增 | 10派1.5元(含税) | 2026-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-23 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-24 |
| 一般消息 | 资产重组 | 公司股权转让 | 2026-01-17 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-12-30 |
| 一般消息 | 高管变动 | 工作调整 | 2025-12-05 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.0行业面打败了79%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.11.13","price":"-0.59","value":"-1.88"},{"date":"2026.11.12","price":"-0.67","value":"-0.19"},{"date":"2026.11.11","price":"0.46","value":"-0.53"},{"date":"2026.11.10","price":"0.08","value":"0.88"},{"date":"2026.11.09","price":"0.32","value":"-0.20"},{"date":"2026.11.06","price":"-1.10","value":"-0.80"},{"date":"2026.11.05","price":"0.10","value":"1.29"},{"date":"2026.11.04","price":"2.16","value":"0.85"},{"date":"2026.11.03","price":"-0.82","value":"0.44"},{"date":"2026.11.02","price":"1.08","value":"1.93"},{"date":"2026.10.30","price":"-1.44","value":"-0.03"},{"date":"2026.10.29","price":"-0.82","value":"-1.62"},{"date":"2026.10.28","price":"0.91","value":"0.86"},{"date":"2026.10.27","price":"-1.33","value":"-2.32"},{"date":"2026.10.26","price":"0.19","value":"0.48"},{"date":"2026.10.23","price":"0.89","value":"0.88"},{"date":"2026.10.22","price":"-1.48","value":"-2.52"},{"date":"2026.10.21","price":"-0.60","value":"-0.15"},{"date":"2026.10.20","price":"0.12","value":"-0.28"},{"date":"2026.10.19","price":"0.39","value":"0.26"},{"date":"2026.10.16","price":"0.24","value":"-0.12"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 维康药业 | 19.82% | 6.81% | 6.0分 |
| 2 | 桂林三金 | 18.87% | -20.44% | 5.6分 |
| 3 | *ST香雪 | 18.68% | 20.08% | 5.7分 |
| 4 | 恩威医药 | 16.18% | 10.05% | 6.1分 |
| 5 | 济川药业 | 15.47% | 2.46% | 7.0分 |
| 6 | 盘龙药业 | 10.29% | 9.63% | 5.5分 |
| 8 | 片仔癀 | 8.00% | -4.12% | 5.7分 |
| 10 | 东阿阿胶 | 6.19% | -0.79% | 6.6分 |
| 12 | 步长制药 | 4.34% | -2.98% | 5.6分 |
| 14 | 信邦制药 | 2.81% | -3.93% | 5.3分 |
| 16 | 马应龙 | 1.30% | -0.64% | 6.2分 |
| 18 | 华润三九 | -0.47% | -1.93% | 6.3分 |
| 20 | 康美药业 | -0.77% | -3.73% | 5.0分 |
| 22 | 亚宝药业 | -1.17% | -1.31% | 4.8分 |
| 24 | 华润江中 | -1.65% | -2.54% | 6.1分 |
| 26 | 同仁堂 | -2.38% | -7.22% | 4.7分 |
| 28 | 白云山 | -2.96% | -3.68% | 5.1分 |
| 30 | 奇正藏药 | -3.29% | -4.34% | 4.9分 |
| 32 | 仁和药业 | -3.74% | -3.55% | 4.7分 |
| 34 | 九芝堂 | -4.75% | -1.91% | 6.0分 |
| 36 | 红日药业 | -5.00% | -5.59% | 4.4分 |
| 38 | ST葫芦娃 | -5.19% | -1.12% | 5.1分 |
| 40 | 陇神戎发 | -5.37% | 3.44% | 5.2分 |
| 42 | 特一药业 | -5.49% | 1.11% | 5.5分 |
| 44 | ST嘉应 | -6.27% | -1.57% | 5.1分 |
| 46 | 新天药业 | -6.58% | -0.26% | 5.0分 |
| 48 | 三力制药 | -6.84% | -3.23% | 5.1分 |
| 50 | 上海凯宝 | -7.75% | -3.73% | 4.6分 |
| 52 | 佛慈制药 | -7.90% | -3.42% | 5.3分 |
| 54 | 沃华医药 | -8.98% | -1.84% | 5.7分 |
| 56 | ST金花 | -9.50% | -4.27% | 4.7分 |
| 58 | 华森制药 | -10.84% | 0.46% | 5.2分 |
| 60 | 古汉医药 | -11.76% | -0.76% | 4.6分 |
| 62 | 中恒集团 | -12.60% | -1.83% | 4.8分 |
| 64 | 益盛药业 | -12.85% | -1.65% | 4.9分 |
| 66 | ST万邦 | -15.12% | -2.01% | 5.2分 |
| 68 | 天目药业 | -17.04% | -5.97% | 4.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-09-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 22/110 ， 31/110。
[{"date":"2026-09-30","value":"7.92","vol":"4.23"},{"date":"2026-06-30","value":"5.35","vol":"3.25"},{"date":"2026-03-31","value":"2.77","vol":"2.21"},{"date":"2025-12-31","value":"6.84","vol":"-2.33"},{"date":"2025-09-30","value":"8.41","vol":"4.80"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.92 | 5.35 | 2.77 | 6.84 | 8.41 |
| 行业(%) | 4.23 | 3.25 | 2.21 | -2.33 | 4.80 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"56.17","vol":"52.92"},{"date":"2026-06-30","value":"56.80","vol":"53.70"},{"date":"2026-03-31","value":"56.74","vol":"55.05"},{"date":"2025-12-31","value":"53.31","vol":"52.85"},{"date":"2025-09-30","value":"53.78","vol":"53.29"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
56.17 | 56.80 | 56.74 | 53.31 | 53.78 |
| 行业(%) | 52.92 | 53.70 | 55.05 | 52.85 | 53.29 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/110 ， 35/110。
[{"date":"2026-09-30","value":"7.12","vol":"-8.01"},{"date":"2026-06-30","value":"10.21","vol":"-9.08"},{"date":"2026-03-31","value":"13.10","vol":"-5.58"},{"date":"2025-12-31","value":"-0.64","vol":"-6.76"},{"date":"2025-09-30","value":"1.27","vol":"-7.84"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
7.12 | 10.21 | 13.10 | -0.64 | 1.27 |
| 行业(%) | -8.01 | -9.08 | -5.58 | -6.76 | -7.84 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"-3.02","vol":"-22.29"},{"date":"2026-06-30","value":"6.83","vol":"-101.51"},{"date":"2026-03-31","value":"4.78","vol":"1.06"},{"date":"2025-12-31","value":"-23.79","vol":"-80.25"},{"date":"2025-09-30","value":"12.65","vol":"-2.78"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-3.02 | 6.83 | 4.78 | -23.79 | 12.65 |
| 行业(%) | -22.29 | -101.51 | 1.06 | -80.25 | -2.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 7/110 ， 21/110。
[{"date":"2026-09-30","value":"0.52","vol":"0.33"},{"date":"2026-06-30","value":"0.37","vol":"0.22"},{"date":"2026-03-31","value":"0.19","vol":"0.12"},{"date":"2025-12-31","value":"0.65","vol":"0.47"},{"date":"2025-09-30","value":"0.50","vol":"0.35"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.52 | 0.37 | 0.19 | 0.65 | 0.50 |
| 行业(次) | 0.33 | 0.22 | 0.12 | 0.47 | 0.35 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"2.02","vol":"1.72"},{"date":"2026-06-30","value":"1.37","vol":"1.14"},{"date":"2026-03-31","value":"0.71","vol":"0.59"},{"date":"2025-12-31","value":"2.42","vol":"2.34"},{"date":"2025-09-30","value":"1.91","vol":"1.72"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.02 | 1.37 | 0.71 | 2.42 | 1.91 |
| 行业(次) | 1.72 | 1.14 | 0.59 | 2.34 | 1.72 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-09-30","value":"17.16","vol":"13.37"},{"date":"2026-06-30","value":"17.81","vol":"20.65"},{"date":"2026-03-31","value":"11.59","vol":"5.83"},{"date":"2025-12-31","value":"27.44","vol":"30.77"},{"date":"2025-09-30","value":"8.12","vol":"10.53"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 17.16 | 17.81 | 11.59 | 27.44 | 8.12 |
| 行业 | 13.37 | 20.65 | 5.83 | 30.77 | 10.53 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"","vol":"0.00"},{"date":"2026-06-30","value":"0.13","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.41","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.13 | - | 0.41 | - |
| 行业 | 0.00 | 0.88 | 0.00 | 1.00 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 5/110 ， 7/110。
[{"date":"2026-09-30","value":"1.87","vol":"3.18"},{"date":"2026-06-30","value":"1.88","vol":"3.10"},{"date":"2026-03-31","value":"1.98","vol":"2.97"},{"date":"2025-12-31","value":"1.87","vol":"2.94"},{"date":"2025-09-30","value":"1.83","vol":"3.09"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.87 | 1.88 | 1.98 | 1.87 | 1.83 |
| 行业 | 3.18 | 3.10 | 2.97 | 2.94 | 3.09 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"1.11","vol":"2.39"},{"date":"2026-06-30","value":"1.13","vol":"2.34"},{"date":"2026-03-31","value":"1.15","vol":"2.23"},{"date":"2025-12-31","value":"1.34","vol":"2.15"},{"date":"2025-09-30","value":"1.10","vol":"2.24"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.11 | 1.13 | 1.15 | 1.34 | 1.10 |
| 行业 | 2.39 | 2.34 | 2.23 | 2.15 | 2.24 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 23/110 ， 27/110。
[{"date":"2026-09-30","value":"29.54","vol":"31.42"},{"date":"2026-06-30","value":"29.37","vol":"32.07"},{"date":"2026-03-31","value":"27.92","vol":"31.94"},{"date":"2025-12-31","value":"28.37","vol":"32.43"},{"date":"2025-09-30","value":"29.33","vol":"31.59"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
29.54 | 29.37 | 27.92 | 28.37 | 29.33 |
| 行业(%) | 31.42 | 32.07 | 31.94 | 32.43 | 31.59 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-09-30","value":"0.43","vol":"0.67"},{"date":"2026-06-30","value":"0.42","vol":"0.68"},{"date":"2026-03-31","value":"0.39","vol":"0.66"},{"date":"2025-12-31","value":"0.40","vol":"0.67"},{"date":"2025-09-30","value":"0.42","vol":"0.76"}]
| 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.43 | 0.42 | 0.39 | 0.40 | 0.42 |
| 行业(%) | 0.67 | 0.68 | 0.66 | 0.67 | 0.76 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 天风证券 | 2026-11-07 | 买入 | |
| 长城证券 | 2026-11-05 | 买入 | 买入 |
| 华创证券 | 2026-11-04 | 增持 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"3.58","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.92","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.22","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"4.74","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"6.10","blueLineValue":"0.24","type":"YC"}]